Kidney Week 2011 Coverage - Renal and Urology News

Sections: Anemia | Transplantation
Secondary Hyperparathyroidism | General News
More: Videos

Kidney Week Coverage

Portable Home Dialysis Unit Improves QoL

Stephan Cho November 16, 2011

PHILADELPHIA—End-stage renal disease patients who dialyzed with a portable hemodialysis (HD) system for 12 months reported improvements in their overall quality of life (QoL), according to findings presented at Kidney Week 2011.

Novel Therapy for CKD Anemia Advances

Stephan Cho November 16, 2011

PHILADELPHIA—A novel treatment for chronic kidney disease (CKD) patients with anemia is showing positive results following a Phase 1/2 clinical trial, according to findings reported at Kidney Week 2011.

Gout Prevalence High in CKD Patients

Jody A. Charnow November 12, 2011

PHILADELPHIA—Patients with chronic kidney disease (CKD) have a relatively high prevalence of gout compared with the general population, according to data presented at Kidney Week 2011.

Lower CKD Risk Found with High Salt Intake

Jody A. Charnow November 12, 2011

PHILADELPHIA—High dietary salt intake may decrease the risk of chronic kidney disease (CKD) and low dietary potassium intake may increase the risk, investigators reported at Kidney Week 2011.

Calcifediol May Improve PTH Control, Nutritional Status

Jody A. Charnow November 12, 2011

PHILADELPHIA—Adequate doses of calcifediol can correct 25-hydroxyvitamin D deficiency and improve malnutrition-inflammation status in hemodialysis (HD) patients with secondary hyperparathyroidism (SHPT), researchers reported at Kidney Week 2011.

IV Iron Drug Shows Advantages in Head-to-Head Trial

Jody A. Charnow November 12, 2011

PHILADELPHIA—Ferumoxytol has an efficacy comparable to iron sucrose in treating iron deficiency anemia in patients with chronic kidney disease (CKD), but is associated with lower adverse event (AE) rates, according to the findings a head-to-head comparison of the two formulations presented at Kidney Week 2011.

Once-Monthly ESA Maintains Stable Hemoglobin Levels

Jody A. Charnow November 12, 2011

PHILADELPHIA—Once-monthly peginesatide, an investigational peptide-based erythropoiesis stimulating agent (ESA), is similar to epoetin administrated one to three times weekly in maintaining mean hemoglobin levels in the 10-12 g/dL range in hemodialysis patients with anemia, according to study findings presented at Kidney Week 2011.

Black Transplant Patients with FSGS Are At Higher Risk

Jody A. Charnow November 12, 2011

PHILADELPHIA—Among kidney transplant recipients with focal segmental glomerulosclerosis (FSGS), African-Americans (AA) have a greater prevalence of risk factors for allograft failure compared with other races, according to findings presented at Kidney Week 2011.

High Pretransplant Phosphorus Raises Post-Transplant Death Risk

Jody A. Charnow November 12, 2011

PHILADELPHIA—High pre-transplant serum phosphorus levels are associated with worse outcomes following renal transplantation, according to study findings presented at Kidney Week 2011.